Please login to the form below
7
Revenue 2017GlaxoSmithKline
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of GlaxoSmithKline's 2013 sales performance.
Pfizer starts RSV trial ahead of winter season
GlaxoSmithKline (GSK) dosed its first patient in a phase 3 trial for its candidate in February; GSK3844766A contains a recombinant subunit pre-fusion RSV antigen (RSVPreF3) combined with a proprietary AS01
GSK/SK bioscience COVID-19 vaccine to enter phase 3 trial
South Korean company SK bioscience (SK)’s COVID-19 vaccine candidate, GBP510, will be compared directly to the AstraZeneca/Oxford University COVID-19 vaccine in a new clinical trial, GlaxoSmithKline (GSK)
Antony Faupel
He has significant UK experience with GlaxoSmithKline and MSD in most therapeutic areas and, also, in specialist and rare diseases with Takeda Europe and Shire Global.
GSK beats expectations thanks to strong vaccine sales in Q2
British drugmaker GlaxoSmithKline (GSK) has beat earnings and revenue expectations after strong sales in its vaccines business boosted its second quarter financials.
EMA begins rolling review of Sanofi, GSK’s COVID-19 vaccine
The European Medicines Agency (EMA) has started a rolling review of Sanofi and GlaxoSmithKline’s (GSK) latecomer COVID-19 vaccine.
[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- AstraZeneca and Innate Pharma to end study on immuno-oncology drug monalizumab
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Boehringer Ingelheim and QUANTRO Therapeutics partner to develop drug candidates
- KOL Ambassador Program & Podcast Creation: A Customer Story
- Supercharging Communication: How Modular Content Can Improve Your Connection With Clients
- Born strategic – Why great strategists are both born and made
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- ONS records a continued fall in UK COVID-19 infections
- ICR research shows how skin cancer cells invade new tissues
- Medmeme appoints Dr Joseph Laudano to medical affairs role
- Gilead announces positive Biktarvy data for HIV and hepatitis B
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Sarepta to submit application for Duchenne muscular dystrophy gene therapy
- Achieving communication excellence by targeting the right channel at the right time
- Successful product commercialisation: what can we learn from the rare disease setting?
PMHub
Dovetail
We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...
Latest intelligence
- KOL Ambassador Program & Podcast Creation: A Customer Story
- ...
- Animation: Living With
- The journey from the patient's perspective...
- Achieving communication excellence by targeting the right channel at the right time
- By Danny Buckland...
